| Income Statement | 2024-06-30 | |||
|---|---|---|---|---|
| Revenue | 30,913 | |||
| Research and development expenses | 155,681 | |||
| Selling, general and administrative expenses | 875,629 | |||
| Cost of revenues | 21,079 | |||
| Costs and expenses | 1,052,389 | |||
| Operating income (loss) | -1,021,476 | |||
| Financingexpense | 3,961,276 | |||
| Interest expense, nonoperating | 671,929 | |||
| Nonoperating income (expense) | -4,633,205 | |||
| Net loss | -5,654,681 | |||
| Deemed dividends | 730,002 | |||
| Net loss attributed to common shareholders, numerator, basic computation | -6,384,683 | |||
| Basic eps | -1.44 | |||
| Diluted eps | -1.44 | |||
| Basic average shares | 4,444,364 | |||
| Diluted average shares | 4,444,364 | |||
null (ARTH)
null (ARTH)